Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

NCT02352831 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Insufficient funding and drug supply from manufacturer

Conditions

Pancreatic Cancer
Cancer of Pancreas
Cancer of the Pancreas
Pancreas Cancer

Interventions

DRUG: Tosedostat
DRUG: Capecitabine
PROCEDURE: Fresh tissue biopsy

Sponsor

Washington University School of Medicine